🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the dose that can be safely given...
Status
Completed
Location
Stanford Cancer Center
Start Date
2008-06
Trial ID
NCT00710528
Treatments Being Tested
This is a phase 1b/2 study to determine the safety and effectiveness of the...
Status
Terminated
Location
Georgia Cancer Center at Augusta University
Start Date
2017-09-26
Trial ID
NCT03257722
Treatments Being Tested
The primary objectives of this study are to evaluate safety, tolerability, ...
Status
Withdrawn
Location
Centre Hospitalier Régional Universitaire de Lille
Start Date
2019-06
Trial ID
NCT03349346
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
To determine the recommended phase 2 dose (RP2D) of idelalisib and venetocl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-02
Trial ID
NCT03639324
The primary objective of this study is to assess the immune response to an ...
Status
Terminated
Location
Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika
Start Date
2018-10-23
Trial ID
NCT03701438
Treatments Being Tested
The primary objective of this study is to evaluate the overall response rat...
Status
Terminated
Location
Pacific Shores Medical Group
Start Date
2015-09-14
Trial ID
NCT02258529
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of TRU-016...
Status
Terminated
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01644253
The investigators expect to enroll 15 participants with relapsed or refract...
Status
Terminated
Location
Boston Medical Center
Start Date
2016-01
Trial ID
NCT02590588
Treatments Being Tested
The primary objectives of this study are to evaluate the safety, tolerabili...
Status
Terminated
Location
Georgetown University Medical Center
Start Date
2015-06-16
Trial ID
NCT02457598
Treatments Being Tested